Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 13, 2016 11:07 AM ET

Healthcare Equipment and Supplies

Company Overview of Marvao Medical Limited

Company Overview

Marvao Medical Limited develops, manufactures, and markets medical devices that reduce the risk of catheter related bloodstream infections (CRBSIs). The company’s NexSite technology reduces the rate of CRBSIs by managing the exit sites of central venous catheters by promoting the formation of a biological seal around the catheter. It provides NexSite CVC products, such as NexSite 9Fr dual and NexSitetm 8Fr single lumen central venous catheters, as well as NexSite hemodialysis and drainage catheters. The company was founded in 2006 and is based in Galway, Ireland.

Dublin Road

GMIT Innovation in Business Centre

Unit 24

Galway,  1


Founded in 2006


353 9 175 9301


353 9 176 2055

Key Executives for Marvao Medical Limited

Co-Founder, Chief Executive Officer, Managing Director and Director
Co-Founder and Director
Company Secretary
Director of Qa/Ra
Compensation as of Fiscal Year 2015.

Marvao Medical Limited Key Developments

Marvao Medical Limited Announces Executive Changes

Marvao Medical Devices Limited announced that medical technology industry leader Eamonn P. Hobbs has been appointed Chairman of the company's board of directors. Mr. Hobbs replaces former board Chairman John Burns, who will continue to serve as a member of the board. Mr. Hobbs brings to Marvao more than 30 years of leadership experience in a number of medical technology industry segments including interventional radiology, oncology, interventional cardiology, surgery, gastroenterology and medical device/pharmaceutical combination products. In 2009 he transitioned from a Delcath Systems Inc. board of directors member to President and CEO and served as Chairman on the Medical Device Manufacturers Association (MDMA) board of directors from 2010 to 2013.

Marvao Medical Receives Second FDA Clearance for Nexsite(TM) HD Catheter Product Line

Marvao Medical has announced that it has received FDA 510(k) clearance for three additional lengths of its NexSite(TM) HD Catheter product line. These new lengths (32cm, 36cm and 40cm) complement the two previously cleared lengths (24cm and 28cm) and complete the core offering of the company's first NexSite(TM) HD catheter product line.

Similar Private Companies By Industry

Company Name Region
Mainstay Medical Limited Europe
Cregstar Bidco Limited Europe
Biosensia Ltd. Europe
Tridelta Development Ltd. Europe
Crescent Diagnostics (Ireland) Ltd. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Marvao Medical Limited, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at